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Abstract. 
In collaboration with the health ministries that we serve and other partners, we set out to complete the multiple-
country Global Trachoma Mapping Project. To maximize the accuracy and reliability of its outputs, we needed 
in-built, practical mechanisms for quality assurance and quality control. This article describes how those 
mechanisms were created and deployed. Using expert opinion, computer simulation, working groups, field 
trials, progressively accumulated in-project experience, and external evaluations, we developed 1) criteria for 
where and where not to undertake population-based prevalence surveys for trachoma; 2) three iterations of a 
standardized training and certification system for field teams; 3) a customized Android phone–based data 
collection app; 4) comprehensive support systems; and 5) a secure end-to-end pipeline for data upload, storage, 
cleaning by objective data managers, analysis, health ministry review and approval, and online display. We are 
now supporting peer-reviewed publication. Our experience shows that it is possible to quality control and 
quality assure prevalence surveys in such a way as to maximize comparability of prevalence estimates between 
countries and permit high-speed, high-fidelity data processing and storage, while protecting the interests of 
health ministries. 
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INTRODUCTION 
Trachoma is the leading infectious cause of blindness.
1
 To help direct global elimination 
of trachoma as a public health problem by 2020,
2
 the Global Trachoma Mapping Project 
(GTMP) aimed to complete the baseline trachoma map worldwide.
3
 Technical, scientific, and 
financial oversight to the GTMP was provided through a complex network of partners with 
complementary mandates, skills, and capacities, including national governments, academic 
institutions, and nongovernmental organizations. A true international collaboration,
4
 the 
GTMP, delivered high-quality
5
 population-based prevalence data on trachoma at 
unprecedented speed and scale. 
Although the singular form of the word “project” is used in its title, the GTMP was 
actually a series of 55 trachoma mapping projects, each of which mapped between one
6–8
 and 
91
9
 evaluation units (EUs) for trachoma. A project covered the trachoma mapping needs of a 
whole country, or of a regional state (Ethiopia) or state (Nigeria). In some projects, a phased 
approach was used, initially mapping a small number of EUs in which the likelihood of 
trachoma being a public health problem was felt to be the greatest, on the basis that mapping 
might be extended if prevalence was found to be high and not extended if it was not. 
Individual projects were owned and operated by health ministries or the local equivalent.
10,11
 
Each EU was mapped using a population-based prevalence survey powered to be 95% 
confident of detecting an expected 10% prevalence of the sign “trachomatous inflammation–
follicular”12 in 1- to 9-year olds, with absolute precision of 3% and a design effect of 2.65.10 
The template methodology has been described in detail elsewhere.
10
 The present article 
documents the steps that were taken in each constituent project, and at global level, to adhere 
to the tenets of that template and to try to maximize the accuracy and application of the 
output. In the spirit of full disclosure, it also lists quality assurance and quality control 
measures that we did not take, either because doing so would have been too expensive or 
impractical or because the prompt to do so came with experience. Some measures in the latter 
category have been introduced for baseline, impact, and surveillance trachoma prevalence 
surveys supported by Tropical Data (www.tropicaldata.org),
13,14
 following the end of the 
GTMP. 
METHODS 
Expert opinion, distilled through a series of teleconferences of the GTMP’s 
Methodologies and Prioritization Working Groups,
10
 was used to develop criteria for where 
to map and where not to map. We used computer simulation to confirm that population-based 
prevalence surveys were needed for mapping,
15
 rather than a quicker and epidemiologically 
dirtier approach. We held meetings and teleconferences of each of the four Working Groups 
(Methodologies, Prioritization, Tools, and Training), and convened the GTMP Advisory 
Committee to oversee development of pilot systems that were then trialed in the field in 
Oromia, Ethiopia, in October 2012.
10
 The training system, electronic data collection app and 
field methodologies were all subsequently refined and enhanced as a result of this experience. 
The GTMP was formally launched on December 17, 2012, and supported trachoma 
prevalence survey fieldwork until January 19, 2016, operating in a total of 29 countries. It 
acquired and processed data on 625,541 households and 2,667,457 examined people. 
Improvements were progressively introduced during rollout, with identification of issues that 
warranted improvement facilitated by weekly teleconferences of the core GTMP team, 10 
periodic meetings of the Advisory Committee, and formal midterm and end-of-project 
evaluations by (different) external consultants. 
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RESULTS 
The criteria used for determining where to map and where not to map are given in the 
Panel. The original field team training manual
16
 was superseded by two revisions: version 2 
from May 24, 2013,
17
 and version 3 from August 15, 2014,
18
 with projects beginning after 
those dates using the updated versions. Quality assurance and quality control points used in 
the GTMP’s systems and methodologies are presented in a series of tables, covering issues 
relating to scope of mapping (Table 1); survey methodology (Supplemental Table 1), 
planning, budgeting, and logistics (Supplemental Table 2); training (Supplemental Table 3); 
survey implementation and field support (Supplemental Table 4); data entry (Supplemental 
Table 5); data management (Supplemental Table 6); data storage (Supplemental Table 7); and 
interpretation, reporting, and application of results (Supplemental Table 8). Common to all of 
these system details was a sequence of development through expertise and experience, 
consensus building, process design, operationalization, feedback, and follow-up. Measures 
were put in place through a combination of first-principles thinking (e.g., Supplemental Table 
3, row 1), critical review of our own and others’ previous work (e.g., Supplemental Table 1, 
row 4), and progressively accumulated experience (e.g., Supplemental Table 2, row 2) 
PANEL 
Criteria for where to map and where not to map used by the GTMP, 2012–2016. 
Where to map: 
• where, on the basis of historical data on trachoma in that district, current data on trachoma in adjacent districts, 
socioeconomic conditions, and access to water and sanitation, the population is very likely to be trachoma 
endemic; or 
• where trichiasis surgery is being performed by local health-care providers; or 
• where individuals with trichiasis are presenting to local health-care providers; or 
• where individuals with trichiasis are being identified as part of community outreach campaigns 
Where not to map: 
• where there is no justification to believe trachoma might be endemic, based on the previously discussed data; 
or 
• where epidemiologically valid prevalence data collected within the last 10 years are already available; or 
• where undertaking mapping might put field teams at a security risk; or 
• where the responsible authorities, following in-depth discussions, do not prioritize elimination of trachoma as 
a public health problem 
DISCUSSION 
“An expert,” Niels Bohr is reported to have said, “is a person who has found out by his 
own painful experience all the mistakes that one can make in a very narrow field.”32 In that 
sense, we regard ourselves as approaching expert status in the conduct of population-based 
prevalence surveys in developing countries. The “painful experience” part of our journeys to 
this point means that this article was not written to give its authors an opportunity to claim 
epidemiological superiority over those who have designed, supervised, participated in, or 
paid for population-based trachoma surveys conducted outside the GTMP. During the course 
of our careers, we have scattered survey design flaws over the trachoma-endemic globe; we 
have tried to document those mistakes here. Within the GTMP, we still did not achieve 
perfection, having had to balance our desire to achieve it with the knowledge that doing so 
would have reduced efficiency. As a particular example, we are aware that GTMP field teams 
often failed to enumerate residents who were eligible to be examined but did not participate,
33
 
despite the fact that our system facilitated it and our field team training system specified 
doing so. We think that the team members were anxious that they would face supervisors’ 
criticism if they achieved much less than 100% enrolment, which is a training and 
communication issue that we tried (and continue to try) to address; we believed that pausing 
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fieldwork to alter enumeration habits would not have been productive. It should also be noted 
that a proportion of the potential problems that we list in the table as things that we attempted 
to avoid or correct in the GTMP are actually ghosts-of-problems-future that we have not 
necessarily yet encountered in real life. However, recognizing and confronting both previous 
failures and near-misses is important, and this article is an attempt to comprehensively 
catalog both the errors that we prevented or detected using the systems and methodologies of 
the GTMP and those that we continue to make and will try to eliminate, where possible, in 
the next phase
13,14
 of population-based data collection to guide trachoma elimination. If our 
experience can be used to help others strengthen the design and execution of their 
community-based surveys at the same time, it will be a double win. 
Field-based surveys are complex undertakings, with many moving parts. We set out to 
generate a whole-of-process system with as few visible joins as possible, supporting survey 
implementation from the point of determining whether a survey was justified, through to 
interpreting health ministry-approved data and applying those data for the purposes of 
improving public health. In such a system, an error in the design or execution of one part of 
the process can have catastrophic effects on the project as a whole. Before the launch of the 
GTMP, therefore, we attempted to ensure that all phases of the implementation process had 
been planned to the fullest possible extent, with decisions made for one phase complementary 
to decisions made for the others; this article in part demonstrates the fruit of those efforts. As 
a high-profile endeavor within the neglected tropical diseases sector, within which there are 
many competing priorities, failure of the GTMP’s systems to work as promised might have 
had reputational consequences for progress against trachoma internationally. 
In that context, implementation of a purely electronic data pathway from collection 
through to display and application carried some risk, both in terms of risk of failure of a 
system built specifically to serve the GTMP, and in terms of the challenge of convincing 
scores of health ministries and other partner organizations to simultaneously jump with us 
from paper to silicon. An occasional objection raised was that without paper forms, we would 
not have the “original record” and would, therefore, be unable to investigate apparent 
problems in the data; this objection ignores the fact that irremediable errors are also made 
when recording data on paper, including many (such as skipped fields, out-of-range values, 
and illegible handwriting) that our app prevented by design. We believe that our recorders’ 
error rate (estimated on the basis of the data on trichiasis in children—all reports of which 
were verified [Supplemental Table 4, row 3]—at 1.4 errors per 10,000 keystrokes) compares 
favorably with previously published data on error rates of data entry operators. Rabbitt found 
that when individuals were asked to electronically record answers to a question with two 
possible responses (an analogy from our surveys would be, “Is there trichiasis in the right 
eye?”), the observed error rate was six per 1,000.34 An outstanding question is whether 
estimates of trachomatous trichiasis prevalence in adults should be automatically corrected 
downward to account for the inevitability of these occasional errors, on the basis that when 
recording the presence or absence of a rare event, erroneous entries are considerably more 
likely to bias prevalence estimates upward than downward. 
The aforementioned question may leave the impression that we felt that we engaged in a 
high-stakes game by setting up to complete the GTMP and choosing electronic data capture. 
We would, therefore, be remiss if we failed to acknowledge that (other than in terms of scale 
and standardization) the GTMP was the setting for an evolution rather than a revolution in 
trachoma surveys. Our collective efforts outlined here owe much to others.
24,35–40
 We think 
we have built on that previous work by making electronic data capture the emerging standard 
for neglected tropical disease epidemiology, by highlighting the need for certification of 
Page 5 of 11 
clinical examination accuracy in field surveys, by emphasizing data quality, and by the 
measures that we have undertaken to ensure local ownership.
5,11
 
Supporting health ministries to fulfill their mandate to lead and encouraging appropriate 
contributions and buy-in from all relevant stakeholders are extremely important issues in their 
own right.
11
 They are also an important step to quality assure future prevalence surveys 
(which will be required to assess the impact of interventions on progress toward 
elimination
41
) because increasing local capacity creates more equal partnerships that will be 
primed to work together on robust survey designs in the next round. 
We are open to constructive criticism from and future collaboration with others and look 
forward to continuing to adapt and improve as we work toward a world in which surveys to 
estimate the prevalence of trachoma eventually become unnecessary.
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TABLE 1 
Preemptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: 
issues relating to the scope of mapping 
No. The GTMP… 
…To reduce the 
impact of, or avoid… 
…Which otherwise 
might have led to… 
Examples of instances 
where this measure 
helped (or might have 
helped) 
1 
Systematically discussed 
countries (and 
administrative divisions 
within countries) with 
individuals who had local 
knowledge, in an effort to 
uncover available evidence 
for possible trachoma 
endemicity, with 
documentation of evidence, 
and action where needed 
Lack of expressed 
need to map in areas 
where mapping is 
needed 
Delay in identification 
of endemic areas, 
delay in elimination 
program initiation, and 
failure to achieve 
GET2020 
The GTMP 
systematically 
discussed the need for 
trachoma surveys in 
the Democratic 
Republic of the Congo 
with key informants
19
 
and the Ministère de la 
Santé
20
 
Lack of expressed 
need to map in areas 
where trachoma was 
historically found but 
has now disappeared 
Continuing uncertainty 
and repeated 
reexamination of the 
same evidence over the 
need or otherwise to 
conduct mapping 
In 1982, a study of 
prevalence and causes 
of blindness and low 
vision was conducted 
in eight provinces of 
Indonesia; trachoma 
was one of the top 10 
causes; by 2013, 
trachoma had 
disappeared 
(unpublished Indonesia 
Ministry of Health 
data) 
2 
(Where evidence to justify 
mapping was of low 
quality) undertook mapping 
using a phased approach 
Failure to take into 
account prevalence 
estimates in adjacent 
areas, as they accrued, 
in decision-making on 
whether there was a 
need to map 
Excessive use of 
resources to document 
the absence of 
trachoma at baseline, 
or delay in 
identification of 
endemic areas, delay in 
elimination program 
initiation, and failure 
to achieve GET2020 
The GTMP phased 
survey rollout in the 
Democratic Republic 
of the Congo,
20
 Yemen 
(manuscript in 
preparation) and 
Zimbabwe
21
 
3 
(Where evidence to justify 
mapping was completely 
absent but suspicion of 
trachoma existed) provided 
technical and financial 
support to undertake 
preliminary survey work to 
determine whether baseline 
population-based 
prevalence surveys were 
Expressed need to map 
in areas where 
mapping was not 
needed 
Excessive use of 
resources to document 
the absence of 
trachoma at baseline 
The GTMP undertook 
preliminary survey 
work in Tanzania to 
rule out areas unlikely 
to have trachoma as a 
public health 
problem
22
 
Lack of expressed 
need to map in areas 
Delay in identification 
of endemic areas, 
The GTMP undertook 
preliminary survey 
Page 10 of 11 
needed where mapping is 
needed 
delay in elimination 
program initiation, and 
failure to achieve 
GET2020 
work in Papua New 
Guinea to provide 
evidence to justify 
population-based 
prevalence surveys
23
 
4 
Used a positive trachoma 
rapid assessment
24
 or other 
positive preliminary data 
on the presence of 
trachoma to initiate support 
for a population-based 
prevalence survey in the 
corresponding 
administrative area, as soon 
as possible 
Assumption that data 
from a trachoma rapid 
assessment provide 
prevalence estimates 
Maximally biased 
estimate of prevalence 
potentially used for 
programmatic 
decision-making 
The GTMP did this for 
the duration of its 
operation 
5 
Initiated contact with 
health ministries of 
countries that may have 
been trachoma endemic 
(and responded to countries 
that reached out to us on 
learning about the GTMP), 
then engaged in discussions 
to determine whether 
mapping was needed 
Countries being 
isolated from the 
international trachoma 
community 
Delay in identification 
of endemic areas, 
delay in elimination 
program initiation, and 
failure to achieve 
GET2020 
Colombia identified 
trachoma in 
communities in the 
Amazon rainforest, 
near to the border with 
Brazil, between 2003 
and 2006,
25
 but limited 
international 
engagement occurred 
until the GTMP visited 
in 2013
26
 
6 
Undertook detailed 
discussions with health 
ministries over the benefits 
and risks associated with 
using the standardized 
systems and approaches of 
the GTMP for trachoma 
mapping, as opposed to 
completing trachoma 
mapping via other means 
Incomplete uptake of 
standardized systems 
and approaches 
developed by the 
GTMP, and/or the 
incomplete use of 
funds allocated to the 
GTMP 
Heterogeneity of 
approaches and/or 
failure to meet donors’ 
expectations 
The GTMP did this for 
the duration of its 
operation 
7 
Channeled financial 
resources donated by 
bilateral organizations to 
undertake baseline 
trachoma mapping in any 
country where baseline 
mapping was justified 
Domestic funds 
available to map 
insufficient to meet 
clear needs 
Delay in identification 
of endemic areas, 
delay in elimination 
program initiation, and 
failure to achieve 
GET2020 
A national survey of 
blindness, low vision, 
and trachoma in 
Ethiopia in 2005–
2006
27
 showed that 
trachoma was highly 
and widely endemic in 
Oromia, the largest 
regional state. But by 
2012, survey work had 
been undertaken in 
only 10 of Oromia’s 
then-current 265 rural 
districts.
28
 The GTMP 
supported mapping of 
the rest of the regional 
state
29
 
8 
Encouraged health 
ministries to piggyback 
collection of data on other 
diseases of local 
importance, advocated to 
funders to secure 
permission to do so, and 
Co-endemic diseases 
with data needs not 
mapped with baseline 
trachoma surveys 
Lost opportunity for 
achieving efficiencies 
in the use of human 
and financial resources 
In two EUs of the 
Solomon Islands and 
one EU of Vanuatu, 
the GTMP collected 
population-based data 
on the prevalence of 
yaws and trachoma at 
Page 11 of 11 
provided technical support 
to adjust fieldwork 
protocols and data 
collection tools as needed 
the same time
6,30,31
 
9 
Supplemented hour-by-
hour communication with 
weekly formal 
teleconferences of the core 
project group, to review 
progress and plan activities, 
country by country 
Centralization of 
information and 
decision-making in the 
hands of one 
individual or one 
partner organization 
Lost opportunities to 
benefit from 
complimentary 
experiences and to 
hear dissenting voices 
The GTMP held 
weekly formal 
teleconferences for the 
duration of its 
operation 
GET20202 = global elimination of trachoma as a public health problem by 2020; GTMP = Global Trachoma 
Mapping Project; EU = evaluation unit. 
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SUPPLEMENTAL TABLE 1 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to survey methodology 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
asked countries to prepare a first draft of 
the survey protocol 
local adoption of a methodology 
without local understanding of why 
each of its elements was important 
failure to build local capacity. The GTMP did this in each of its 
constituent projects. 
imposition of locally inappropriate 
survey elements if local partners 
feel inhibited about challenging a 
template 
difficulties in survey 
implementation. 
2 
ensured that the draft survey protocol 
was consistent with WHO 
recommendations, working with the 
health ministry and local partners to 
refine the draft as needed 
international inconsistency prevalence estimates that could 
not be compared between settings. 
The GTMP did this in each of its 
constituent projects. 
3 
assisted countries to frame EUs of 
appropriate sizes (generally at the level of 
the local administrative unit for health 
care management and ideally containing 
framing of inappropriately large 
EUs 
potential to miss significant 
pockets of disease. 
In Yobe State, Nigeria, a previous 
population-based trachoma 
prevalence survey covered a 
population of > 2 million people in 
2 
 
populations of 100,000–250,000 
persons35) 
a single EU.43 
framing of inappropriately small 
EUs 
excessive use of resources for 
mapping, or extrapolation of 
results from a small EU to provide 
prevalence estimates for a larger 
population.44 
In the Solomon Islands, the regions 
of Rennell-Bellona (estimated 
population 3041) and Temotu 
(estimated population 21 362) had 
sufficiently similar socio-economic 
and environmental characteristics 
to be combined to form a single 
EU.31 
4 
assisted countries to design 
epidemiologically valid cluster selection 
methods within EUs 
selection of too many clusters excessive use of resources for 
mapping. 
Due to a misunderstanding, twice 
the required number of clusters 
were selected and visited in one 
GTMP-Mozambique EU that had 
been formed by combining 2 
adjacent districts. We subsequently 
included explicit discussion of the 
implications of EU formation on 
cluster selection in our 
conversations with health 
ministries. 
selection of too few clusters potential to miss significant 
pockets of disease. 
In some trachoma prevalence 
surveys conducted prior to the 
GTMP, 7–14 clusters were selected 
for inclusion.45–47 
selection of clusters using a biased generation of inaccurate All GTMP-supported surveys 
applied epidemiologically-
3 
 
methodology prevalence estimates. appropriate cluster selection 
methods. 
5 
assisted countries to design 
epidemiologically valid household 
selection methods within clusters 
selection of too many households excessive use of resources for 
mapping, either through enrolment 
of an excessive total number of 
households per EU, or through 
making the workload required in 
one cluster too great to be reliably 
completed by one team in a single 
day. 
In 1999, in order to select an 
appropriate sub-village for a 
longitudinal study, AWS and his 
team examined 5527 of 5703 
residents (some or all residents of 
1099 of 1103 households) of a 
single trachoma-endemic village in 
Tanzania,48 for reasons that he is 
now unable to fully explain. It took 
him and one other experienced 
grader nearly 3 months of full-time 
work. 
selection of too few households failure to achieve an appropriate 
sample size, or inefficiency through 
having field teams unproductive 
for long periods of each day. 
All GTMP-supported surveys 
involved selection of 25–45 
households per selected cluster. 
selection of households using a 
biased methodology 
generation of inaccurate 
prevalence estimates. 
For the first few clusters enrolled in 
the Democratic Republic of the 
Congo, teams only visited 
households that had children; this 
was noted by our data manager 
and corrected via a telephone call. 
6 selected a fixed number of households 
per cluster, rather than a fixed number of 
perceived pressure to enrol 
individuals causing coercion of 
abrogation of ethical The GTMP did this in each of its 
constituent projects, except in Viet 
4 
 
individuals cluster residents or biased 
sampling, particularly towards the 
end of the day in the field 
responsibilities, or selection bias. Nam.49 
7 
developed a standard smartphone app 
for data collection and supplied it for use 
in all countries, allowing any changes in 
practice to be quickly incorporated 
through the app   
lag in practice behind policy, which 
lags behind learning 
continued implementation of 
known flaws. 
The GTMP’s purpose was to 
complete baseline trachoma 
mapping, but it soon received 
requests to support impact and 
surveillance surveys41 for 
trachoma, too. At these phases of 
programme evolution, the 
prevalence of trichiasis “unknown 
to the health systema”35 is 
important. This led rapidly to the 
incorporation into the standard 
survey of questions about previous 
management in eyes recorded as 
having trichiasis.18 
8 
designed surveys to include collection of 
global positioning system data from each 
household enrolled 
failure to include independently 
verifiable geolocation of selected 
households and clusters 
inability to ensure that households 
and clusters have been 
appropriately enrolled. 
In one constituent project of the 
GTMP, one team logged all 
households in 2 clusters at a single 
location in the national capital, 
several hundred kilometres from 
the EU ostensibly being surveyed. 
Following further investigation on 
the ground by the health ministry, 
those data were rejected and the 
                                                          
a
 This excludes cases that have already been operated on, for which operations have been refused, or which are already scheduled to receive operations. 
5 
 
team members redeployed away 
from the GTMP. 
9 
enrolled, as standard, all residents aged 
≥1 year in each household selected for 
inclusion  
failure to examine adults (or 
examination of adults only if they 
lived in the same house as 1–9-
year-olds50) 
inability to estimate a meaningful 
prevalence (or generation of a 
potentially biased estimate of the 
prevalence50) of trachomatous 
trichiasis. 
Within the GTMP, 3 EUs in Chad 
and 3 EUs in Egypt had to be re-
surveyed because field teams only 
examined 1–9-year-olds; in 
Cambodia, only households in 
which 1–9-year-olds lived were 
enrolled50; in Viet Nam, only 1–9-
year-olds and ≥50-year-olds were 
enrolled.49 
failure to examine children47 inability to estimate a meaningful 
prevalence of trachomatous 
inflammation—follicular. 
The GTMP did this in each of its 
constituent projects. 
creation of an incentive for 
household residents very keen to 
be examined, or very keen not to 
be examined, to misrepresent their 
age 
bias in prevalence estimates. In recent trials of a trachomatous 
trichiasis-only survey methodology, 
when only those aged ≥40 years 
were examined, unexpectedly large 
numbers of individuals claiming to 
be aged 40–45 years were 
enrolled.51 
10 
supported health ministries to obtain 
local ethical clearance before surveys 
started 
neglect of locally important ethical 
considerations in survey design 
failure to “take into consideration 
the laws and regulations of the 
country or countries in which the 
research is to be performed as well 
as applicable international norms 
The GTMP did this in each of its 
constituent projects. 
6 
 
and standards”, as required by the 
Declaration of Helsinki.52 
 
 
SUPPLEMENTAL TABLE 2 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to planning, budgeting and 
logistics 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
closely reviewed budgets against the 
agreed methodology and a standard 
budget template and ensured that the 
methodology was consistently reflected 
in the budgeting assumptions53 
essential activities omitted, or 
excessive resources requested to 
undertake mapping 
mapping activities not aligned with 
agreed methodology, inefficient 
use of resources, or shortfall in 
funding with consequent failure of 
one or more of the GTMP’s 
constituent project. 
Resources to support field team 
supervisors added to budgets in 
several projects. In one country, 
excessive requests were trimmed, 
resulting in a budget reduction of 
28%.  
2 
provided Android smartphones for survey 
teams, with (if possible) survey forms 
already pre-loaded 
possible local purchase of phones 
with outdated versions of the 
Android operating system and/or 
difficulties in ensuring correct 
software installation 
delays in commencing surveys, or 
reversion to the use of paper-
based data collection. 
The GTMP tried to do this in each 
of its constituent projects. Where it 
did not (because, for example, it 
was difficult to import phones, or 
lead times were too short), phone 
cost was often higher, and internet 
bandwidth occasionally made it 
challenging to download survey 
software. 
7 
 
3 
provided binocular, 2.5× magnifying 
loupes for graders to use 
lack of provision of loupes by 
programmes; or provision of 
loupes that were uncomfortable to 
wear, prone to breakage, or of the 
wrong magnification 
failure to use loupes, or use of 
loupes with the wrong 
magnification, leading to reduction 
in diagnostic accuracy. 
The GTMP did this in each of its 
constituent projects. 
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SUPPLEMENTAL TABLE 3 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to training 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
provided a standard training system for 
graders and recorders,18 and required 
individuals to be certified in its use before 
using it to train others10 
different training systems, or 
different interpretation of the 
same training system, delivered to 
teams in different projects; and 
duplication of effort 
variable quality training. Over the course of its 3-year 
operation, the GTMP used 3 
successive versions of a 
standardized training system.10 
2 
provided all elements of the standard 
training system in English, French, Arabic, 
Spanish and Portuguese,18 having had the 
accuracy of translation in each case 
checked by ophthalmologists with that 
language as a mother tongue  
differential attention to quality 
control and quality assurance in 
different settings, depending on 
language preference 
variable quality training. All 3 iterations of the GTMP’s 
standardized training system were 
made available in 5 languages.10 
3 
trained local trachoma grader trainers, or 
(where there were insufficient human 
resources to meet the local training need) 
identified and funded GTMP-certified 
grader trainers from elsewhere to 
participate in training 
human resources available to train 
local staff insufficient to meet the 
agreed need 
delay in identification of endemic 
areas, delay in elimination 
programme initiation, and failure 
to achieve GET2020. 
The GTMP funded a GTMP-certified 
grader trainer from the Solomon 
Islands to visit Vanuatu to train and 
certify local personnel as trachoma 
graders6; there were many other 
instances of similar collaboration 
within the GTMP. 
9 
 
4 
assisted newly GTMP-certified trainers 
undertaking their first GTMP training 
week by providing a fellow trainer with 
previous experience of delivering GTMP 
training 
trepidation or uncertainty Inconsistency in field team training 
between sites. 
The GTMP tried to do this in each 
of its constituent projects; it was 
not possible in some instances 
because of travel restrictions. 
5 
(where there was an absolute shortage of 
medical and paramedical personnel to 
train as graders) brokered secondments 
of GTMP-certified graders from 
elsewhere to assist with mapping 
understaffed field teams scarce personnel deployed to the 
field for long periods to complete 
surveys, or mapping not attempted 
at all. 
The GTMP did this on several 
occasions; the details are 
somewhat politically sensitive. 
6 
insisted on strict adherence to the 
definitions of signs in the WHO simplified 
trachoma grading scheme12 
often: over-diagnosis, because 
graders do not want to ignore 
obvious pathology; this stems from 
confusion between the role of a 
grader contributing to a prevalence 
survey (where definitions must be 
clear cut), and the role of a 
clinician caring for an individual 
(where knowledge of the natural 
history of disease and factors other 
than the patient’s clinical signs 
contribute to formulating the 
management plan) 
overestimation of the prevalence 
of trachoma, potentially leading to 
inappropriate allocation of 
resources for trachoma 
elimination. 
In Togo in 2009, graders classified 
individuals with fewer than 5 
follicles as having TF.54 
7 
undertook all grader training in known 
trachoma-endemic areas, and 
incorporated examination in the field as 
deployment of graders who may 
not have previously had an 
opportunity to examine real 
subjects with the signs they are 
uncertainty about grader 
competence. 
The GTMP supported grader 
trainees from Lao People’s 
Democratic Republic59 and 
Cambodia50 to be trained in 
10 
 
part of the training process then asked to identify55–58 Ethiopia, at the invitation of the 
Oromia Regional Health Bureau. 
8 
only deployed graders who had 
demonstrated their trachoma grading 
competency through formal inter-grader 
agreement exercises on real subjects, 
using the assessments of a GTMP-
certified grader trainer10 as the gold 
standard 
deployment of graders whose 
competency had been assessed 
only through grading of slides or 
photographs of trachoma55–58,60 
uncertainty about grader 
competence. 
The GTMP did this in each 
constituent project, other than Viet 
Nam,49 where travel of grader 
trainees to a more highly endemic 
country could not be undertaken. 
Though not allowing previously-
experienced graders who did not 
pass the test to continue was 
controversial at the beginning, it 
was subsequently seen as an 
important demonstration of how 
important quality was to the 
GTMP. In some contexts, however, 
managing disappointed grader 
trainees became an issue in its own 
right. 
9 
set the standard for passing the inter-
grader agreement exercise as a kappa of 
≥0.70 for the presence or absence of the 
sign “trachomatous inflammation—
follicular” in children aged 1–9 years 
use of percentage agreement with 
the grader trainer,43,46,61–63,64 or an 
unspecified measurement,45,65 as 
the criterion for diagnostic 
accuracy 
uncertainty about grader 
competence. 
The GTMP did this in each of its 
constituent projects, other than 
Viet Nam (see above). 
10 
made the training system available for 
countries engaged in impact surveys for 
trachoma, even if they were conducted 
different training systems delivered 
to teams in different settings; and 
duplication of effort to create 
variable quality of training. The GTMP training system was 
made available to India, Mali and 
Nepal for use in trachoma 
prevalence surveys that health 
11 
 
without other involvement of the GTMP training systems ministries in those countries had 
planned to implement 
independently. 
 
12 
 
 
 SUPPLEMENTAL TABLE 4 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to survey implementation and 
field support 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
deployed in-service supervisors, each of 
whom were required to first pass the 
formal inter-grader agreement exercises 
on real subjects, using as the gold 
standard the assessments of a GTMP-
certified grader trainer 
lack of appropriate supervisionb drift in accuracy of grading over 
time; errors in application of 
fieldwork protocol; or unreported 
social, economic, health or supply 
issues that could adversely affect 
field team performance.  
The GTMP did this in each of its 
constituent projects. 
2 
rapidly reviewed raw data 
 
over-estimation of the mean 
number of residents per household 
in available census data 
failure to examine a number of 
individuals in each EU that would 
permit calculation of prevalence 
estimates with acceptable 
precision.c  
In Southern Nations, Nationalities 
and Peoples’ Region of Ethiopia,66 
we requested that 4 clusters be 
added to an EU because there 
were too few 1–9-year-olds 
examined. 
                                                          
b
 We intend to further improve the standard and consistency of supervision in trachoma impact and surveillance surveys, through the use of a dedicated training package 
for supervisors 
c
 We did not keep a sufficiently close eye on this issue early in project implementation. (In Oromia, for example, there were 2 EUs in which 651 and 653 1–9-year-olds were 
initially examined, but because of delays in data upload, teams had moved to other zones before this came to light.) Pre-GTMP surveys which stipulated a given number of 
subjects to be examined per cluster did not run this risk, but instead risked biased selection. 
13 
 
under-estimation of the mean 
number of residents per household 
in available census data 
examination of more individuals in 
each EU than necessary to permit 
calculation of prevalence estimates 
with acceptable precision, leading 
to inefficient use of resources.d 
In Guinea, where 23 clusters were 
included per EU, the range of 1–9-
year-olds examined per EU was 
1113–3137. 
 
3 
telephoned field supervisors as soon as a 
record of trachomatous trichiasis in a 
child was identified 
erroneous recording of the 
presence of trachomatous 
trichiasis in a child 
potential mobilisation of a 
paediatric ophthalmologist or 
oculoplastic surgeon to provide 
service; or if undetected, tacit 
encouragement of a lack of 
concentration in the field. 
In raw data from 55 projects, 519 
cases of trichiasis were reported 
amongst 1 146 644 1–9-year-olds; 
249 of those cases were confirmed 
when checked with field teams. 
4 
discussed and resolved fieldwork 
problems as they arose  
uncertainty, confusion, 
inconsistency between teams 
reductions in the accuracy and/or 
repeatability of prevalence 
estimates. 
The GTMP did this in each of its 
constituent projects. 
 
 
                                                          
d
 We did not do this well enough. Pre-GTMP surveys which stipulated a given number of subjects to be examined per cluster did not run this risk, but instead risked biased 
selection. 
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SUPPLEMENTAL TABLE 5 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to data entry 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
undertook all primary data recording in 
electronic format, using a purpose-built 
Android smartphone app, LINKS-
GTMP10,36 
failure to ensure high-fidelity 
transfer of data from paper to 
electronic format for the purposes 
of data analysis, and/or long delays 
while paper-based surveys are 
managed (photocopied, double 
entered, etc.) 
data used to generate prevalence 
estimates not reflecting the 
findings observed in the field, 
and/or long intervals between 
survey completion and 
programmatic decision-making. 
The GTMP did this in each of its 
constituent projects. 
2 
ensured that the LINKS-GTMP app did not 
permit fields to be skippede 
failure to collect or record available 
data 
missing data, and uncertainty in 
analyses. 
The GTMP did this in each of its 
constituent projects. 
3 
included “don’t know” and/or “other” 
options in all multiple choice questions 
data recorders being forced to 
stop, enter junk data or use a 
parallel reporting system 
junk data, loss of system integrity 
or inability to proceed. 
The GTMP did this in each of its 
constituent projects. 
4 
used check screens requesting recorders 
to verify data just entered 
lack of flagging of entry of rare 
outcomes, such as trachomatous 
missed opportunities to correct 
erroneous keystrokes at source. 
The GTMP did this in each of its 
constituent projects.  
                                                          
e
 The dangers inherent in allowing skip fields are illustrated by the GPS data collected (for each household) in the GTMP. Because GPS signals are sometimes difficult or 
impossible to access, LINKS-GTMP allows recorders to proceed to the next question without collecting GPS coordinates, which teams were instructed to press only after the 
Android had tried to triangulate its location for at least 60s without success. In one project, a group of recorders rapidly developed a habit of always skipping the GPS field. 
In our next-generation app developed for Tropical Data, skipping GPS data collection is only possible after system-driven timeout. 
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trichiasis 
5 
restricted responses to sensible ranges – 
age, for example, could only be recorded 
as 1–100 years; for those reporting an 
age at last birthday of > 100 years, 100 
years was recorded 
errors potentially uninterpretable data. The GTMP did this in each of its 
constituent projects. 
 
 
SUPPLEMENTAL TABLE 6 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to data management 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
undertook data cleaning centrally (by BKC 
from 12/2012–06/2013; by RW from 
07/2013–07/2015; by RW and AB from 
07/2015–01/2016; identical algorithms 
were used throughout) 
inconsistency and/or lack of 
objectivity in data cleaning 
random error or bias. The GTMP did this in each of its 
constituent projects. 
2 
checked that clusters lay within the 
boundaries of the EU by comparing the 
mean GPS coordinates of the households 
enrolled in a cluster with the EU shape-
filef 
inclusion of data from clusters that 
were inadvertently selected from 
outside the boundaries of the EU 
potentially inaccurate estimation 
of trachoma prevalence for the EU. 
The GTMP did this in each of its 
constituent projects. 
                                                          
f
 Accurate shape-files were often unavailable. In such cases, discussion with local staff was used to resolve uncertainties. 
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3 
adjusted trachomatous inflammation—
follicular prevalence data by age of 
subjects examined10 
implied failure to recognise that 
those examined in a house-to-
house survey may not necessarily 
be representative of the underlying 
population, because of absence, 
refusal, or illness 
bias in estimates of prevalence. The GTMP did this in each of its 
constituent projects. 
4 
adjusted trachomatous trichiasis data by 
age and gender of subjects examined 10 
implied failure to recognise that 
those examined in a house-to-
house survey may not necessarily 
be representative of the underlying 
population, because of absence, 
refusal, or illness 
bias in estimates of prevalence of 
trachomatous trichiasis, usually 
leading to overestimation. 
The GTMP did this in each of its 
constituent projects. 
5 
equally weighted cluster-level outcome 
proportions when considering overall 
prevalence 
over-emphasis of results on 
clusters with larger numbers or 
examined individuals 
sampling or participation bias. The GTMP did this in each of its 
constituent projects. 
6 
in projects commencing after 15 August 
2014, classified trichiasis as trachomatous 
trichiasis if and only if the eyelid 
demonstrated easily visible conjunctival 
scarring 12, or could not be everted 
implied failure to recognise that 
not all trichiasis is due to trachoma 
misclassification bias in estimates 
of prevalence of trachomatous 
trichiasis, leading to 
overestimation. 
Since adding collection of data on 
conjunctival scarring, 69% of all 
trichiasis recorded in GTMP 
surveys has been trachomatous 
trichiasis. 
7 
developed standard data analysis 
algorithms to be run in R  
human error erroneous output. The GTMP did this in each of its 
constituent projects. 
8 
double-checked all output by eye human error, or unintended 
consequences of the use of 
standard algorithms 
erroneous outputs. The GTMP did this in each of its 
constituent projects. 
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9 
made the R code used freely available to 
any interested party (including as 
Supplementary information to this paper) 
higher barrier to replication of 
analyses 
scepticism. For the R code, please see 
Supplementary information. 
10 
used a 2-stage health ministry data 
approval process and insisted on health 
ministry ownership of data 10 
lack of acknowledgement of 
national ownership of data 
delay or failure in application of 
outputs to disease control. 
The GTMP did this in each of its 
constituent projects. (The lack of 
an analogous process for routinely 
engaging, at the planning stage, 
government officials responsible 
for water, sanitation and hygiene 
(WASH) occasionally led to 
tensions over household-level 
WASH data, which were collected 
in nearly all constituent projects of 
the GTMP.67,68) 
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SUPPLEMENTAL TABLE 7 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to data storage 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
programmed LINKS-GTMP to 
automatically upload data from micro-SD 
cards to a Cloud-located database, as 
soon as a data-enabled mobile phone 
network or WiFi network was detected 
electronic data maintained in only 
one place, or in an insufficient 
number of places 
need for repeat survey in the event 
of loss, damage or corruption of 
storage media.  
The GTMP did this in each of its 
constituent projects. 
2 
applied 128-bit encryption at the 
transport layer,10 and carried out 
subsequent data review, cleaning and 
approval only through a secure website 
with transport layer security, IP-restricted 
firewall, and site authentication and 
authorization, to which access could be 
gained only through password-protected 
login. 
paper-based or electronic data 
containing personally identifiable 
information stored without 
adequate security 
potential inadvertent disclosure of 
personally identifiable information 
on survey subjects, violating 
standard ethical principles for 
investigators.  
The GTMP did this in each of its 
constituent projects; for Tropical 
Data,13, 14 256-bit encryption is 
being used, including encryption of 
data at rest. 
3 
went to extreme lengths to recover data 
stored on micro-SD cards that were, in 
the rare case, damaged in the field 
loss of data and potential loss of 
faith in the reliability of data 
storage on Android smartphones 
possible need to repeat surveys, 
and possible need to design a new 
system. 
The GTMP lost data from 1 cluster 
(due to a lost Android), of a total of 
12,631 clusters visited. Where 
Androids were damaged or 
corrupted, all stored data were 
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recovered. 
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SUPPLEMENTAL TABLE 8 
Pre-emptive and corrective measures put in place by the GTMP to avoid pitfalls inherent in trachoma mapping: issues related to interpretation, reporting 
and application of results 
 
 The GTMP… 
…to reduce the impact of, or 
avoid… 
…which otherwise might have led 
to… 
Examples of instances where this 
measure helped (or might have 
helped) 
1 
built capacity amongst collaborating 
partners in an effort to ensure that 
disaggregated data, if examined, were 
interpreted correctly 
assumption that cluster-level data 
can be used to provide prevalence 
estimates for the cluster,64 or for a 
subdivision of the EU43 
decisions made using data not 
powered to provide the estimates 
generated. 
The GTMP did this in each of its 
constituent projects. 
2 
calculated 95% confidence intervals for 
prevalence estimates by bootstrapping 
adjusted cluster-level proportions, with 
replacement, over 10,000 replications 
confidence intervals around 
prevalence estimates not 
calculated, not calculated using an 
appropriate methodology, or not 
reported 
assessment of precision of 
prevalence estimates made 
difficult. 
The GTMP did this in each of its 
constituent projects. 
3 
provided epidemiologist support to local 
authors, as needed, to draft project-
specific manuscripts once each project 
was complete; and brokered agreement 
to publish the resulting papers, if 
accepted under the journal’s normal 
criteria, in a series of supplements to a 
peer-reviewed journal, with financial 
support from the project to make those 
data not published in peer-
reviewed journals 
lower visibility of data and of local 
efforts. 
There has been considerable 
interest in the published output of 
the GTMP, with a number of 
special issues of Ophthalmic 
Epidemiology5,81 produced. 
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papers open-access8,9,22,23,29,31,50,59,66,69–80 
4 
automatically channelled prevalence 
category data to the open access website 
of the Global Atlas of Trachoma,82,83 with 
explicit health ministry agreement, as 
soon as they were fully approved by the 
health ministry 
prevalence category data not made 
widely available  
data not accessible for public 
health decision-making.  
The GTMP did this in each of its 
constituent projects. 
5 
(if  the health ministry explicitly agreed), 
electronically transferred prevalence data 
to the International Trachoma Initiative, 
so that they could be used, where 
indicated, to justify applications for 
donated azithromycin for trachoma 
elimination purposes 
manual transfer of data increased effort, delays, errors. GTMP data have leveraged a 
probable donation of 283 283 514 
doses of azithromycin from Pfizer 
(including doses already donated, 
those approved for donation, and 
doses projected for future 
donation based on standard 
numbers of treatment rounds). 
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